Tivity Health Inc (NASDAQ:TVTY)’s stock price shot up 5.5% during trading on Wednesday . The stock traded as high as $16.26 and last traded at $16.25, 749,336 shares were traded during mid-day trading. A decline of 34% from the average session volume of 1,131,531 shares. The stock had previously closed at $15.40.
Several research firms have commented on TVTY. Cantor Fitzgerald restated a “buy” rating and issued a $27.00 price target on shares of Spero Therapeutics in a research note on Thursday, May 9th. Zacks Investment Research downgraded shares of Hess Midstream Partners from a “hold” rating to a “sell” rating in a research note on Tuesday, May 14th. Craig Hallum initiated coverage on shares of Tivity Health in a research note on Thursday, April 11th. They set a “buy” rating and a $30.00 target price for the company. Barrington Research set a $5.00 target price on shares of U.S. Auto Parts Network and gave the stock a “buy” rating in a research note on Friday, May 10th. Finally, BidaskClub upgraded shares of Xilinx from a “hold” rating to a “buy” rating in a research note on Wednesday. Two research analysts have rated the stock with a sell rating, one has given a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $33.00.
The company’s fifty day moving average price is $17.13. The company has a debt-to-equity ratio of 2.13, a current ratio of 0.86 and a quick ratio of 0.71. The firm has a market capitalization of $725.08 million, a price-to-earnings ratio of 6.94, a PEG ratio of 0.63 and a beta of 1.05.
Tivity Health (NASDAQ:TVTY) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.01. Tivity Health had a net margin of 12.18% and a return on equity of 26.02%. The business had revenue of $214.10 million for the quarter, compared to analyst estimates of $200.39 million. During the same period in the previous year, the business posted $0.49 earnings per share. The business’s revenue was up 42.8% compared to the same quarter last year. As a group, equities research analysts forecast that Tivity Health Inc will post 2.35 EPS for the current year.
Several institutional investors have recently modified their holdings of TVTY. NJ State Employees Deferred Compensation Plan grew its holdings in Tivity Health by 40.0% during the 2nd quarter. NJ State Employees Deferred Compensation Plan now owns 30,000 shares of the company’s stock worth $493,000 after acquiring an additional 8,574 shares in the last quarter. James Investment Research Inc. grew its holdings in Tivity Health by 50.1% during the 2nd quarter. James Investment Research Inc. now owns 22,865 shares of the company’s stock worth $376,000 after acquiring an additional 7,630 shares in the last quarter. State of New Jersey Common Pension Fund D grew its holdings in Tivity Health by 166.0% during the 2nd quarter. State of New Jersey Common Pension Fund D now owns 410,000 shares of the company’s stock worth $6,740,000 after acquiring an additional 255,848 shares in the last quarter. Eqis Capital Management Inc. acquired a new position in Tivity Health during the 2nd quarter worth $367,000. Finally, New Jersey Better Educational Savings Trust acquired a new position in Tivity Health during the 2nd quarter worth $230,000.
Tivity Health Company Profile (NASDAQ:TVTY)
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.